Skip to main content
Top

Drugs

Issue 7/2016

Content (8 Articles)

Ivabradine: Cardioprotection By and Beyond Heart Rate Reduction

  • Current Opinion

Gerd Heusch, Petra Kleinbongard

Iatrogenic Iron Overload in Dialysis Patients at the Beginning of the 21st Century

  • Open Access
  • Current Opinion

Guy Rostoker, Nosratola D. Vaziri, Steven Fishbane

Drug-Induced Dyskinesia, Part 1: Treatment of Levodopa-Induced Dyskinesia

  • Review Article

Dhanya Vijayakumar, Joseph Jankovic

Drug-Induced Dyskinesia, Part 2: Treatment of Tardive Dyskinesia

  • Review Article

Dhanya Vijayakumar, Joseph Jankovic

Naphthoquine: An Emerging Candidate for Artemisinin Combination Therapy

  • Review Article

Brioni R. Moore, Moses Laman, Sam Salman, Kevin T. Batty, Madhu Page-Sharp, Francis Hombhanje, Laurens Manning, Timothy M. E. Davis

Idebenone: A Review in Leber’s Hereditary Optic Neuropathy

  • Adis Drug Evaluation

Katherine A. Lyseng-Williamson

Susoctocog Alfa: A Review in Acquired Haemophilia A

  • Adis Drug Evaluation

Celeste B. Burness, Lesley J. Scott

Obiltoxaximab: First Global Approval

  • AdisInsight Report

Sarah L. Greig

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images